Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome.
Ontology highlight
ABSTRACT: Adult rats treated concomitantly with insulin and human chorionic gonadotropin exhibit endocrine, metabolic, and reproductive abnormalities that are very similar to those observed in polycystic ovary syndrome (PCOS) patients. In this study, we used this rat model to assess the effects of metformin on PCOS-related uterine dysfunction. In addition to reducing androgen levels, improving insulin sensitivity, and correcting the reproductive cycle, metformin treatment induced morphological changes in the PCOS-like uterus. At the molecular and cellular levels, metformin normalized the androgen receptor-mediated transcriptional program and restored epithelial-stromal interactions. In contrast to glucose transport, uterine inflammatory gene expression was suppressed through the PI3K-Akt-NFκB networ
SUBMITTER: Zhang Y
PROVIDER: S-EPMC5405166 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA